Barcode readability for DSCSA 2023 interoperability
AmerisourceBergen and McKesson conducted barcode assessments to gain an up-to-date view of industry’s progress in implementing serialisation requirements of the 2013 Drug Supply Chain Security Act.
Body
Cardinal Health conducted its own barcode assessment of homogeneous cases from pharmaceutical manufacturers. All three assessments were supported by GS1 Healthcare US.
Taking a consistent, year-over-year approach, the teams from AmerisourceBergen and McKesson with collaboration from GS1 Healthcare US scanned 2D barcodes on product packages, capturing data to measure the percentage of readable 2D barcodes encoding an NDC, serial number, lot number and expiration date.
